Year: 2023

IRVINE, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) — Shimmick Corporation (“Shimmick”), a leading water infrastructure company, today announced the pricing of its initial public offering of 3,575,000 shares of its common stock at a price to the public of $7 per share. Shimmick has also granted the underwriters in the offering a 30-day option to purchase up to an additional 536,250 shares at the initial public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on the Nasdaq Global Market on November 14, 2023 under the ticker symbol “SHIM.” The offering is expected to close on November 16, 2023, subject to the satisfaction of customary closing conditions. Shimmick intends to use the net proceeds from the offering to repay outstanding indebtedness, with any remaining amounts to be used...

71% of TV viewers in Southeast Asia watch ad-supported streaming SINGAPORE, Nov. 14, 2023 (GLOBE NEWSWIRE) — Magnite (NASDAQ: MGNI), the world’s largest independent sell-side advertising company, today unveiled its latest research study Streaming TV’s New Era: Embracing Ad-supported Streaming Across Screens in Southeast Asia. The research, which spans markets including Singapore, Indonesia, Philippines, Thailand and Vietnam, finds that ad-supported streaming services deliver scale and impact for brands and that 71% of TV viewers in Southeast Asia watch ad-supported streaming, closing the gap with traditional TV viewers. The study reveals that ad-supported streamers are spending an average of two hours a day watching streaming content and embracing content across devices. These cross-device viewing habits generate more meaningful...

CAPE CANAVERAL, Fla., Nov. 13, 2023 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced that its scientists and executives will present and participate in meetings at three upcoming medical and investor conferences in November. Vaccines Summit – 2023Date: Tuesday, November 14, 2023 Time: 12:20 – 12:40 p.m. (ET)Title: UB-612: A novel peptide/protein subunit COVID-19 vaccine booster stimulated broadly neutralizing and Fc-mediated effector antibodies in a head-to-head Phase 3 randomized clinical trial Jefferies London Healthcare Conference Date: Wednesday, November 15, 2023 Time: 4:30 – 4:55 p.m. (GMT)Format: Fireside chat Evercore ISI 6th Annual HealthCONx Conference Date: Wednesday, November 29, 2023Time: 10:25 – 10:45 a.m. (ET)Format: Fireside...

MILWAUKEE, Nov. 13, 2023 (GLOBE NEWSWIRE) — STRATTEC SECURITY CORPORATION (NASDAQ:STRT) (“STRATTEC” or the “Company”), today announced that Frank J. Krejci, President and Chief Executive Officer, will retire from employment with the Company effective December 31, 2023. He will also retire from the Company’s Board of Directors on December 31st. Mr. Krejci became a member of STRATTEC’s inaugural Board of Directors in 1995 and has been a valued Board member for over 28 years. He became an Officer of STRATTEC in 2010, serving as President, and has served as President and Chief Executive Officer since September 1, 2012. Rolando Guillot, Senior Vice President – Operations and Chief Operating Officer, has been named to serve as Interim Chief Executive Officer effective January 1, 2024 in addition to his current role.   Mr. Guillot joined...

MELBOURNE, Australia, Nov. 13, 2023 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to invite shareholders to attend an investor webinar on The Watchlist, to be held on Tuesday, 14th November, 2023, 1:00pm AEDT/10:00am AWST. CEO Steven Lydeamore will provide an overview and update on the business and upcoming milestones. Following the presentation, attendees will have the opportunity to ask questions directly to Mr Lydeamore during a moderated Q & A session. This webinar can be viewed live via zoom & you register via the link below. Zoom: https://share.hsforms.com/1ccfJimCATYqzCkvIKIC7VAd16zr A recorded copy of the webinar and presentation will be available on the Company’s website following the event. Authorised for release...